Dive Brief:
- 3D printing may still be in the R&D stage in biopharma—but there have been notable successes developing antibiotic-containing catheters, as in-Pharmatechnologist reports.
- In addition, Dr. Horacio D'Agostino and his team at Louisiana State University have constructed filaments, beads, and stents that contained either antibiotics or chemotherapeutic agents.
- D'Agostino and his team are convinced that 3D printing has "limitless potential" in terms of interventional radiology as it relates to patient care.
Dive Insight:
Currently Dr. D'Agostino and his team are prototyping products, with the goal of eventually being able to print patient-customized catheters and stents on demand.